Danimer Scientific, Inc.
DNMR · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $47 | $53 | $59 | $47 |
| % Growth | -12.3% | -9.4% | 24.1% | – |
| Cost of Goods Sold | $74 | $64 | $58 | $36 |
| Gross Profit | -$27 | -$8 | $1 | $11 |
| % Margin | -57.7% | -14.9% | 1.5% | 24.2% |
| R&D Expenses | $29 | $32 | $20 | $8 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $69 | $82 | $80 | $19 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $66 | $0 | $0 |
| Operating Expenses | $99 | $180 | $100 | $27 |
| Operating Income | -$126 | -$187 | -$99 | -$16 |
| % Margin | -269.1% | -352.2% | -169.2% | -33.2% |
| Other Income/Exp. Net | -$30 | $7 | $26 | $7 |
| Pre-Tax Income | -$155 | -$181 | -$73 | -$9 |
| Tax Expense | $0 | -$1 | -$13 | $0 |
| Net Income | -$155 | -$180 | -$60 | -$9 |
| % Margin | -333% | -337.8% | -102.3% | -18.7% |
| EPS | -1.52 | -1.78 | -0.65 | -0.1 |
| % Growth | 14.6% | -173.8% | -550% | – |
| EPS Diluted | -1.52 | -1.78 | -0.65 | -0.1 |
| Weighted Avg Shares Out | 102 | 101 | 93 | 85 |
| Weighted Avg Shares Out Dil | 102 | 101 | 93 | 85 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $30 | $2 | $1 | $2 |
| Depreciation & Amortization | $29 | $20 | $12 | $5 |
| EBITDA | -$96 | -$103 | -$88 | -$2 |
| % Margin | -205.9% | -194.5% | -149.3% | -3.8% |